Auto stocks face headwinds despite Trump’s tariff pause, with many underperforming expectations due to domestic economic concerns and muted Q4FY25 earnings. While some stocks like Eicher and TVS have shown resilience, brokerages anticipate earnings downgrades across the sector due to weak demand and plateauing margin expansion. Experts recommend stock-specific strategies, highlighting Maruti Suzuki, Ashok Leyland, and M&M as potential buys.
5 pharma stks with upside potential of up to 12%
Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to
June 12, 2025